Tommaso Caravita

Tommaso Caravita

UNVERIFIED PROFILE

Are you Tommaso Caravita?   Register this Author

Register author
Tommaso Caravita

Tommaso Caravita

Publications by authors named "Tommaso Caravita"

Are you Tommaso Caravita?   Register this Author

54Publications

1229Reads

29Profile Views

Patient-reported outcomes in relapsed/refractory multiple myeloma: a systematic review.

Support Care Cancer 2018 Jul 20;26(7):2075-2090. Epub 2018 Mar 20.

Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Via Benevento, 6, 00161, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-018-4137-xDOI Listing
July 2018

Hematologists and nephrologists working together: moving forward with a new integrated care model for blood-related malignancies?

Blood Res 2017 Sep 25;52(3):218-219. Epub 2017 Sep 25.

Nephrology Unit, Department of Medical Specialties S. Eugenio Hospital (ASL Roma 2), Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5045/br.2017.52.3.218DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641515PMC
September 2017

Towards a better understanding of the relationship between side effects of analgesia and quality of life in patients with multiple myeloma.

Support Care Cancer 2016 Jan 4;24(1):9-10. Epub 2015 Aug 4.

Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-015-2868-5DOI Listing
January 2016

Chronic myelomonocytic leukemia coexisting with monoclonal gammopathy: concomitant response to azacitidine of both disorders.

Ann Hematol 2015 Oct 20;94(10):1753-4. Epub 2015 Jun 20.

Hematology Unit and Pathology Department, Sant'Eugenio Hospital, Piazzale dell'Umanesimo 10, 00144, Rome, Italy,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-015-2431-yDOI Listing
October 2015

Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma.

J Clin Oncol 2015 Oct 17;33(30):3459-66. Epub 2015 Aug 17.

Antonio Palumbo, Francesca Gay, Federica Cavallo, Alessandra Larocca, Francesca Donato, Chiara Cerrato, Luana Boccadifuoco, and Mario Boccadoro, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino; Giulia Benevolo, S.C. Ematologia A.O. Città della Salute e della Scienza di Torino; Tommasina Guglielmelli, University of Turin and San Luigi Hospital; Giovannino Ciccone, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino and CPO Piemonte, Torino; Francesco Di Raimondo, Ospedale Ferrarotto, Azienda Policlinico-OVE, University of Catania, Catania; Maria T. Petrucci, Sapienza University of Rome; Tommaso Caravita, Ematologia Ospedale S. Eugenio, Rome; Sara Pezzatti, Azienda Ospedaliera San Gerardo, Monza; Francesca Patriarca, DISM, University Hospital, Udine; Chiara Nozzoli, AOU Careggi, Florence; Donatella Vincelli, A.O "Bianchi-Melacrino-Morelli," Reggio Calabria; Pellegrino Musto, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Referral Cancer Center of Basilicata, Rionero in Vulture; Paolo Corradini, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milano, Milano; Michele Cavo, Institute of Hematology and Medical Oncology "Seràgnoli," Bologna University School of Medicine S. Orsola's University Hospital, Bologna, Italy; Izhar Hardan, Meir Medical Center, Kfar-Saba; Arnon Nagler, Tel Aviv University, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Roman Hajek, University Hospital Ostrava and University of Ostrava, Ostrava, Czech Republic; Michel Delforge, University Hospital Leuven, Leuven, Belgium; Zhinuan Yu and Christian Jacques, Celgene, Summit, NJ; and Meletios A. Dimopoulos, National and Kapodistrian University of Athens, School of Medicine, Alexandra Hospital, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.2466DOI Listing
October 2015

Autologous transplantation and maintenance therapy in multiple myeloma.

N Engl J Med 2014 Sep;371(10):895-905

From the Myeloma Unit, Division of Hematology, University of Turin (A.P., F.C., F.G., C. Cerrato, M.G., P.O., M.B.), and Unit of Clinical Epidemiology and Centro di Referimento per l'Epidemiologia-Piemonte, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino (A.E., G.C.), Turin, Division of Hematology, Ospedale Ferrarotto, Azienda Policlinico-Ospedale Vittorio Emanuele, University of Catania, Catania (F.D.R.), Hematology, Sapienza University of Rome (M.T.P.), and Cattedra di Ematologia, Ospedale S. Eugenio-University Tor Vergata (T.C.), Rome, Divisione di Ematologia, Ospedale S. Gerardo, Monza (S.P.), La Struttura Complessa di Ematologia, Dipartimento di Ematologia ed Oncologia, Azienda Ospedaliera Niguarda Ca' Granda (A.C.), Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute (M.M.), and Division of Hematology and Bone Marrow Transplantation, IRCCS Istituto Nazionale dei Tumori-University of Milan (P.C.), Milan, Ematologia, Policlinico Federico II, Naples (L.C.), Clinica di Ematologia, Azienda Ospedaliera Universitaria Ospedali Riuniti di Ancona, Ancona (M.O.), Unità Operativa Complessa Ematologia 1, IRCCS Azienda Ospedaliera Universitaria San Martino-Istituto Nazionale per la Ricerca sul Cancro, Genoa (A.M.C.), Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna (E.Z., M.C.), Clinica Ematologia, Dipartimento di Scienze Mediche Sperimentali e Cliniche, Azienda Ospedaliera-Universitaria di Udine, Udine (F.P.), Scientific Direction, IRCCS, Centro di Riferimento Oncologico della Basilicata, Rionero in Vulture (P.M.), and Struttura Complessa Ematologia e Dipartimento Oncologia Medica, Spedali Civili di Brescia, Brescia (C. Crippa) - all in Italy; and the Hematology Division, Hadassah University Hospital, Jerusalem (D.B.Y.), and the Hematology Institute, Chaim Sheba Medical Center, Tel Hashomer (E.R., A.N.) - both in Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1402888DOI Listing
September 2014

High-dose epoetin alfa as induction treatment for severe anemia in multiple myeloma patients.

Int J Hematol 2009 Sep 16;90(2):270-272. Epub 2009 Jul 16.

Department of Hematology, University "Tor Vergata", St. Eugenio Hospital, Rome, Italy.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12185-009-0378-2
Publisher Site
http://dx.doi.org/10.1007/s12185-009-0378-2DOI Listing
September 2009

Bortezomib: efficacy comparisons in solid tumors and hematologic malignancies.

Nat Clin Pract Oncol 2006 Jul;3(7):374-87

Myeloma Unit, Hematology Department, St Eugenio Hospital, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncponc0555DOI Listing
July 2006

Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma.

Cancer 2005 Oct;104(7):1428-33

Divisione di Ematologia dell'Università di Torino, Azienda Ospedaliera S. Giovanni Battista, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.21342DOI Listing
October 2005

Efficacy of low-dose thalidomide and dexamethasone as first salvage regimen in multiple myeloma.

Hematol J 2004 ;5(4):318-24

Divisione di Ematologia dell'Università di Torino, Azienda Ospedaliera S Giovanni Battista di Torino, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.thj.6200403DOI Listing
February 2005